Search
Search Results
##search.searchResults.foundPlural##
-
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1911PDF: 838HTML: 231 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2310PDF: 759HTML: 2147Untitled: 252Untitled: 174Untitled: 206Untitled: 179Untitled: 197Untitled: 205Untitled: 211 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3331PDF: 969HTML: 3230 -
THE ROLE OF WHITE BLOOD CELL COUNT IN PERIANAL PATHOLOGIES: A RETROSPECTIVE ANALYSIS OF HEMATOLOGIC MALIGNANCIES Role of white blood cell count in perianal pathologies
4088PDF: 2015HTML: 275 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1607PDF: 1152HTML: 264 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2757PDF: 794HTML: 2326 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
2998PDF: 1003HTML: 7498 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4622PDF: 1788HTML: 1239 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2666PDF: 978HTML: 594 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9345PDF: 6213HTML: 88096Fig.1b: 224Fig.1c: 224Fig.2a: 207Fig.2b: 206Fig.4: 228Fig.2c: 208Fig.3: 210Tab.1: 264Tab.2: 242Tab.3: 225Tab.4: 256Fig1a: 221 -
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2570PDF: 1361HTML: 1828CoverLetter: 206 -
OUTBREAK OF BURKHOLDERIA CEPACIA INFECTION: A SYSTEMATIC STUDY IN A HEMATOLOGY-ONCOLOGY UNIT OF A TERTIARY CARE HOSPITAL FROM EASTERN INDIA.
2362PDF: 985HTML: 502Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 247UntitOutbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern Indialed: 376Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 277Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 200Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 214Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 289 -
Idiopathic pulmonary embolism in a case of severe family ANKRD26 thrombocytopenia
2339PDF: 874HTML: 969Patient’s family tree: 202 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2239PDF: 1041HTML: 4097Cover Letter: 244Figure 1: 258Figure 2: 251Table 1: 232 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2299PDF: 1845HTML: 843 -
Bilateral Pleural Effusions due to Pulmonary Amyloidosis as the Presenting Manifestation of Multiple Myeloma
1406PDF: 801HTML: 4413Figure 1: 181Untitled: 162Untitled: 215 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2521PDF: 1228HTML: 1071 -
DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY
2034PDF: 851HTML: 2216Table 1: 206Table 2: 221Table 3: 221Table 4: 221Table 5: 217Tble 6: 211Cover Letter: 231Greene Tab.7: 230 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2600PDF: 1747HTML: 550 -
A MULTICENTER EXPERIENCE FROM LEBANON IN CHILDHOOD AND ADOLESCENT ACUTE MYELOID LEUKEMIA:HIGH RATE OF EARLY DEATH IN CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA.
3342PDF: 1160HTML: 7747cover letter paper final AML: 244 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3727PDF: 2604HTML: 1635 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1499PDF: 967HTML: 254 -
PERSISTENT COLONIC SCHISTOSOMIASIS AMONG SYMPTOMATIC RURAL INHABITANTS IN THE EGYPTIAN NILE DELTA Colonic schistosomiasis among rurals of the Egyptian Nile delta
1695PDF: 537MP4: 453Html: 302 -
Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study Ceftolozane-Tazobatam for febrile neutropenia
7968PDF: 755HTML: 255 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1860PDF: 912HTML: 1474 -
INCREASE IN CANDIDA PARAPSILOSIS CANDIDEMIA IN CANCER PATIENTS
1877PDF: 1108HTML: 303







